IDS-ISYS Human Growth Hormone (HGH) Launch

Immunodiagnostic Systems Holdings plc (“IDS”), a leading producer of diagnostic testing kits for the clinical and research markets, announces the launch of a newly-developed fully-automated immunoassay for human Growth Hormone (hGH), the third new product to appear on the IDS-iSYS Immunoanalyser since its launch in February 2009.

Growth hormone is the major factor involved in the regulation of growth, and its measurement is essential in identifying the cause of numerous important growth disorders. The global market for hGH immunoassay is estimated to be ca €8.0 million.